Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-08-28FDA Approved: DASATINIB — Supplemental Application (Apotex Corp.)
The FDA approved Apotex Corp.'s supplemental application for dasatinib (DASATINIB).
-
FDA approval · 2025-08-28FDA Approved: DASATINIB — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for dasatinib (generic), enabling the continued availability of a generic DASATINIB thr…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Newly-diagnosed Pediatric T-cell ALL Protocol [Phase 2, Phase 3]
This clinical trial update describes a pediatric protocol for newly diagnosed T-cell acute lymphoblastic leukemia entering Phase 2/3 and cur…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes [Phase 2]
Phase 2 trial update evaluating the infusion of expanded cord blood cells in addition to a single cord blood transplant for patients with ac…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol [Phase 2, Phase 3]
A newly diagnosed, low-risk pediatric B-cell acute lymphoblastic leukemia protocol is described for Phase 2 and Phase 3 testing and is curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: A Bioavailability Study of Nilotinib in Healthy, Adult, Human Subjects Under Fasted Conditions. [Phase 1]
A Phase 1 bioavailability study of nilotinib in healthy adult participants under fasted conditions has been completed.
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Squishy Toy and Palpation in Pediatric IV Success [NA]
A completed clinical trial from Akdeniz University evaluating a squishy toy-assisted palpation technique to improve intravenous access succe…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies [Phase 4]
Phase 4 trial comparing ciprofloxacin to ceftazidime as empirical therapy for high-risk febrile neutropenia in children with hematologic can…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell [Phase 1, Phase 2]
A completed Phase 1/2 study from Stanford evaluated a haploidentical hematopoietic cell transplantation approach using a T-cell depleted gra…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.
A clinical trial update describing the safety study of BESPONSA (inotuzumab ozogamicin) in pediatric patients with acute lymphoblastic leuke…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Impact of a mHealth Supportive Tool on Cardiopulmonary Resuscitation' Situational Awareness [NA]
This clinical trials registry entry describes a pediatric study evaluating a mobile health tool to improve situational awareness during card…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae [NA]
Clinical trial update for a study evaluating Goal Management Training for adult survivors of childhood acute lymphoblastic leukemia and chil…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: HEalth Advocate for Liver Transplant - Pilot [NA]
This entry notes a pilot clinical trial called Health Advocate for Liver Transplant that is currently recruiting, focusing on liver transpla…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL [EARLY_Phase 1]
An early-phase trial evaluating the safety and feasibility of CD19 CAR T cells manufactured with the CliniMACS Prodigy platform for relapsed…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies [Phase 1, Phase 2]
Clinical trial update on CLIC-1901 for relapsed/refractory CD19-positive hematologic malignancies (Phase 1/Phase 2), currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Effect of Music Therapy Applied During Lumbar Puncture on Infants' Pain Perception [NA]
A clinical trial update indicates enrollment is ongoing for a study evaluating whether music therapy during lumbar puncture reduces pain per…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative
Clinical trial update noting ongoing recruitment for a study assessing the incidence of invasive fungal infections in adults with Ph-negativ…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation [Phase 2]
This clinical trial update describes a Phase 2 study evaluating TCRγδ T cells and memory T cells with selective use of blinatumomab as part …
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating tagraxofusp in combination with low-intensity chemotherapy for CD123-positive relapsed or refractory acute lympho…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Muscle Dysfunction in Patients With Haematological Diseases
This clinical trial update describes a study on muscle dysfunction in patients with hematologic diseases, including acute myeloid leukemia, …
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 2]
Juventas Cell Therapy is conducting a Phase 2 trial of CNCT19 cell injection for relapsed or refractory acute lymphoblastic leukemia, curren…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia
A clinical trial evaluating the role of SF3B1 mutation in assessing acute lymphoblastic leukemia and chronic lymphocytic leukemia; the study…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells [Phase 2]
This clinical trial update reports long-term follow-up data from patients treated with Autolus' autologous CAR T cell therapy in multiple my…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 4]
Pfizer's Phase 4 trial of Inotuzumab Ozogamicin in Chinese patients with relapsed or refractory acute lymphoblastic leukemia has completed a…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Phase I Dose Finding Study of MB-CART2219.1 [Phase 1]
This clinical trial update reports that a Phase I dose-finding study of MB-CART2219.1 is currently recruiting at University Hospital Tuebing…